Skip to main content
AMCR logo

AMCR · Amcor plc

Track AMCR — free
Market Cap
$19.55B
Shares
462.35M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$41.90 Open$42.12 Day$41.82–42.29 52W close$36.69–50.58 Avg vol 30d3.6M Short int19.3M · 4.2% float · 5.3d Short vol62% Last earningsAug 12, 2026 DataJan 2020–Sep 2026 Filing10-K · Aug 14

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 7 wks
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$23.51B
Trailing 12 months
Net income (TTM)
$1.11B
Trailing 12 months
Revenue growth YoY
+25.9%
Year over year
Operating margin
8.1%
Trailing 12 months
P / E (TTM)
17.6
Trailing earnings · reciprocal yield 5.7%
FCF yield
6.3%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
12.4%
Trailing 12 months
Shares change YoY
+60.4%
Year over year · more shares
Price change (1Y)
Trailing year
Short interest
4.2%
Latest settlement · 5.3 days to cover
View all 115 metrics

AI Brief

Q4 FY26 earnings call · Aug 12, 2026
Q4 FY26

TL;DR. AMCR delivered strong FY26 results with adjusted EPS up 13% to $4.02 and Q4 adjusted EPS up 23% to $1.23, driven by Berry synergies that beat plan. For the six-month transition period, the company guided adjusted EPS of $1.80–$1.90, and signaled double-digit adjusted EPS growth and ~3x leverage by year-end 2027.

Bullish
  • + FY26 adjusted EPS rose 13% to $4.02, meeting double-digit growth target.
  • + Berry synergies reached $285M in FY26, ~$10M ahead of initial year-one target.
  • + Volumes inflected to modestly positive in Q4 with ~200bps sequential improvement across categories.
  • + Company guided to double-digit adjusted EPS growth in calendar 2027 with leverage to ~3x.
  • + Quarterly dividend raised modestly to $0.65/share, continuing annual dividend growth.
Bearish
  • FY26 free cash flow of $1.3B was $200M below the outlook range due to Middle East conflict working capital impacts.
  • Higher interest and tax represent a $0.10–$0.12 unfavorable drag to EPS in the transition period.
  • Healthcare volumes remain weak due to softness in lower-margin subcategories.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Weak Sentiment Bullish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −2%
below
Price vs 50-day avg −7%
below
RSI (14) 33
neutral
MACD trend Negative
52-week position 38%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −12%
trailing
6-month return +8%
trailing
YTD return 0%
this year
Relative strength −12%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $45 › 200d $43 — 50d above 200d
Institutional flow Accumulating
+2% holders QoQ · +113 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.17% of float · ▼ -9.8% MoM · 5.3 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
698 holders — mid 3-yr range
Squeeze score 56
elevated · 0–100
Fundamentals
Excellent
Revenue growth +9%
Y/Y
Gross margin 34%
expanding
EPS growth +49%
Y/Y
Free cash flow $1.8B
Valuation P/E 17.8
in line
Buyback $321.0M
remaining
Balance sheet $12.9B
net debt
Quant / Vol
risk profile
Moderate
Volatility 31%
annualized · 1-yr
Max drawdown −27%
past year
ATR 2.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 12, 2026
the six months ending December 31st 2026
Adjusted EPS Non-GAAP $1.80 – $1.90
transition period
Adjusted EPS Non-GAAP $1.80 – $1.90
Prior guidance period ended · from the 8-K filed Aug 15, 2024
Adjusted Free Cash Flow · twelve month period ending June 30, 2025 $900M – $1B
Effective tax rate · fiscal 2025 19% – 20%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 5 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−2% Neutral
Price vs 50-day avg
−7% Bearish
RSI (14)
33 Neutral
MACD trend
Negative Bearish
52-week position
38% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $45 › 200d $43 — 50d above 200d
Institutional flow Accumulating
+2% holders QoQ · +113 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.17% of float · ▼ -9.8% MoM · 5.3 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
698 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $37 Now $42 · 38% Range high $51
vs 200-day avg -2% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted net income non-GAAP $1.86B fiscal year 2026 filing
GAAP → non-GAAP reconciliation
GAAP Adjusted EBIT $2.81B
-$676M Interest expense
+$29M Adjustments to interest expense
-$181M Income tax expense
-$188M Adjustments to income tax expense
+$66M Interest income
+$0M Net income attributable to non-controlling interests
= Adjusted net income $1.86B
Adjusted Segment EBIT non-GAAP $2.97B fiscal 2026 filing
Share options outstanding 8.6M fiscal year 2026 filing
Adjusted Diluted EPS non-GAAP $4.02 Fiscal Year Ended June 30, 2026
Adjusted EBITDA non-GAAP $3.67B Fiscal Year Ended June 30, 2026
Adjusted Free Cash Flow non-GAAP $1.59B Twelve Months Ended June 30, 2026
approximately 400 locations 400 Fiscal Year Ended June 30, 2026
approximately 75,000 Amcor people 75,000 Fiscal Year Ended June 30, 2026
Free Cash Flow non-GAAP $1.3B Twelve Months Ended June 30, 2026
Net debt non-GAAP $12.9B June 30, 2026

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaging & Containers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AMCR
Amcor plc
this stock
$19.55B +56.6% 17.8 4.2%
SW
Smurfit Westrock plc
$23.25B +14.6% +47.7% 47.2 4.3%
PKG
Packaging Corp Of America
$20.74B +12.9% +7.2% 30.2 3.0%
IP
International Paper Co /New/
$18.83B -12.3% +49.3% 8.5%
BALL
BALL Corp
$16.15B +13.6% +11.6% 17.4 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
698
% held
78.2%
Net QoQ
+13.9M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
197
View
Short & Settlement
Short Interest Falling
Shares short
19.3M
Days to cover
5.3d
Change
-2.1M sh
View
Short Volume
Short vol %
62%
As of
Sep 21, 2026
Short Total
View
Fails to Deliver
FTD shares
4.0K
Value
$192.4K
As of
Aug 24, 2026
View
Off-Exchange
Off-exchange %
42.2%
Week of
Aug 17, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Thomas H. Kean
Amount
$1.0K–$15.0K
Traded
Aug 10, 2026
View
Financials
Financials
Revenue (FY)
$23.5B
Net income (FY)
$1.1B
EPS diluted
$2.38
View
Buybacks
Remaining
$321.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 14, 2026
This year
11
View
Proposed Sales
Value
$1.4M
Shares
30.0K
Filed
Feb 6, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 12, 2026
View

Performance

5D 20D 120D MTD YTD
AMCR -1.0% -12.4% +8.5% -8.7% +0.5%
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY -0.7% -12.2% -11.6% -8.0% -11.2%

Capital returns

Latest dividend
$0.65 / share · ex Sep 4, 2026
Raised 1.6%
Paid (TTM)
$2.60 / share · 4 payouts
Dividend yield (TTM, derived)
6.21%
Buyback program · as of Sep 28, 2024
Authorized
Spent (derived)
Remaining
$321.00M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1748790 CUSIP G0250X149 13F (30d) 12 filings 11 filers Visit website Investor relations